Novel Off-label use of Cangrelor for prevention of hepatic artery thrombosis following pediatric liver transplantation (ISTH 2026) - May 25, 2026 - Abstract #PB2312; Pres time: Jul 13, 2026; 01:45 PM - 02:45 PM; Location: Exhibition Hall- Poster Area; "There were 4 (36%) bleeding events, 2 requiring intra- abdominal intervention; 2 experienced minor bleeding; one had hematochezia, and one had hematemesis Conclusions In this early experience, Cangrelor appears to be a safe option for prevention of thrombotic complications in pediatric liver transplant recipients while awaiting initiation of aspirin. These findings support the need for larger, well-designed multicenter studies to better assess the safety and efficacy of Cangrelor after pediatric liver transplantation DOI*10.1016/j.rpth.2026.105052"
Clinical • Cardiovascular • Hematological Disorders • Pediatrics • Thrombosis • Transplantation
|
|
Omid Hosseini 1; Lisa Hensch 1; Howard Pryor 1; Moreshwar Desai 1; Jun Teruya 1; Dana Cerminara 1; Anna Banc-Husu 1; Kevin Huang 1; John Goss 1; Nhu Thao Galvan 1; Dalia Bashir 1
|